U.S. Hemp Roundtable 2022 Year-In-Review



It’s been three years since COVID struck our nation. As the economy continues to recover, so does the hemp industry. It was a slow and steady process, but hemp managed to make up some ground in 2022.

Across the states, the U.S. Hemp Roundtable worked with lawmakers on two significant issues: how we treat intoxicating hemp-derived products, such as delta-8 THC, and how we protect non-intoxicating hemp products, such as CBD, from onerous regulation. On Capitol Hill, the Roundtable continued to call on Congress to require the Food and Drug Administration (FDA) to regulate CBD and other hemp extracts while laying the groundwork for key advancements for the industry as part of the upcoming 2023 Farm Bill.

The progress we made will serve as a necessary precursor for what we hope to accomplish in what could be a monumental 2023, given the pending Farm Bill.

Check out our 6th annual year-in-review recapping our work in 2022!
https://hempsupporter.com/news/2022-year-in-review

source